Patents by Inventor Cornelia Jutta Forster

Cornelia Jutta Forster has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SUSTAINED RELEASE DELIVERY SYSTEMS COMPRISING TRACELESS LINKERS
    Publication number: 20230201353
    Abstract: Described herein are drug delivery systems for delivering biologically active agents comprising primary or secondary amines, or a ring nitrogen atom of an azaheteroaryl ring, pharmaceutically acceptable salts thereof, drug delivery reagents related thereto, pharmaceutical compositions comprising the drug delivery systems, and the use of the drug delivery systems as sustained release therapeutics.
    Type: Application
    Filed: November 11, 2022
    Publication date: June 29, 2023
    Inventors: Christopher M. ADAMS, Myriam APRIL, Tanzina FAZAL, Cornelia Jutta FORSTER, Edward Charles HALL, Cameron Chuck-munn LEE
  • SUSTAINED DELIVERY OF ANGIOPOETIN-LIKE 3 POLYPEPTIDES
    Publication number: 20220323595
    Abstract: Described herein are drug delivery systems for delivering biologically active agents comprising primary or secondary amines, or a ring nitrogen atom of an azaheteroaryl ring, pharmaceutically acceptable salts thereof, drug delivery reagents related thereto, pharmaceutical compositions comprising the drug delivery systems, and the use of the drug delivery systems as sustained release therapeutics.
    Type: Application
    Filed: May 26, 2022
    Publication date: October 13, 2022
    Inventors: Christopher M. ADAMS, Myriam APRIL, Tanzina FAZAL, Cornelia Jutta FORSTER, Nicole GERWIN, Edward Charles HALL, Jean-Baptiste Georges Armand LANGLOIS, Cameron Chuck-munn LEE
  • Sustained delivery of angiopoetin-like 3 polypeptides
    Patent number: 11389541
    Abstract: Described herein are drug delivery systems for delivering biologically active agents comprising primary or secondary amines, or a ring nitrogen atom of an azaheteroaryl ring, pharmaceutically acceptable salts thereof, drug delivery reagents related thereto, pharmaceutical compositions comprising the drug delivery systems, and the use of the drug delivery systems as sustained release therapeutics.
    Type: Grant
    Filed: October 2, 2019
    Date of Patent: July 19, 2022
    Assignee: NOVARTIS AG
    Inventors: Christopher M. Adams, Myriam April, Tanzina Fazal, Cornelia Jutta Forster, Nicole Gerwin, Edward Charles Hall, Jean-Baptiste Georges Armand Langlois, Cameron Chuck-munn Lee
  • SUSTAINED RELEASE DELIVERY SYSTEMS COMPRISING TRACELESS LINKERS
    Publication number: 20200376129
    Abstract: Described herein are drug delivery systems for delivering biologically active agents comprising primary or secondary amines, or a ring nitrogen atom of an azaheteroaryl ring, pharmaceutically acceptable salts thereof, drug delivery reagents related thereto, pharmaceutical compositions comprising the drug delivery systems, and the use of the drug delivery systems as sustained release therapeutics.
    Type: Application
    Filed: June 15, 2020
    Publication date: December 3, 2020
    Inventors: Christopher M. ADAMS, Myriam APRIL, Tanzina FAZAL, Cornelia Jutta FORSTER, Edward Charles HALL, Cameron Chuck-munn LEE
  • Sustained release delivery systems comprising traceless linkers
    Patent number: 10751417
    Abstract: Described herein are drug delivery systems for delivering biologically active agents comprising primary or secondary amines, or a ring nitrogen atom of an azaheteroaryl ring, pharmaceutically acceptable salts thereof, drug delivery reagents related thereto, pharmaceutical compositions comprising the drug delivery systems, and the use of the drug delivery systems as sustained release therapeutics.
    Type: Grant
    Filed: April 19, 2018
    Date of Patent: August 25, 2020
    Assignee: Novartis AG
    Inventors: Christopher M. Adams, Myriam April, Tanzina Fazal, Cornelia Jutta Forster, Edward Charles Hall, Cameron Chuck-munn Lee
  • SUSTAINED DELIVERY OF ANGIOPOETIN-LIKE 3 POLYPEPTIDES
    Publication number: 20200108153
    Abstract: Described herein are drug delivery systems for delivering biologically active agents comprising primary or secondary amines, or a ring nitrogen atom of an azaheteroaryl ring, pharmaceutically acceptable salts thereof, drug delivery reagents related thereto, pharmaceutical compositions comprising the drug delivery systems, and the use of the drug delivery systems as sustained release therapeutics.
    Type: Application
    Filed: October 2, 2019
    Publication date: April 9, 2020
    Inventors: Christopher M. ADAMS, Myriam APRIL, Tanzina FAZAL, Cornelia Jutta FORSTER, Nicole GERWIN, Edward Charles HALL, Jean-Baptiste Georges Armand LANGLOIS, Cameron Chuck-munn LEE
  • SUSTAINED RELEASE DELIVERY SYSTEMS COMPRISING TRACELESS LINKERS
    Publication number: 20180303945
    Abstract: Described herein are drug delivery systems for delivering biologically active agents comprising primary or secondary amines, or a ring nitrogen atom of an azaheteroaryl ring, pharmaceutically acceptable salts thereof, drug delivery reagents related thereto, pharmaceutical compositions comprising the drug delivery systems, and the use of the drug delivery systems as sustained release therapeutics.
    Type: Application
    Filed: April 19, 2018
    Publication date: October 25, 2018
    Inventors: Christopher M. ADAMS, Myriam APRIL, Tanzina FAZAL, Cornelia Jutta FORSTER, Edward Charles HALL, Cameron Chuck-munn LEE
  • Organic compounds
    Patent number: 8703761
    Abstract: The invention relates to compounds of formula (I): where A is an optionally substituted heteroaryl, useful for treating disorders mediated by acyl coA-diacylglycerol acyl transferase 1 (DGAT1), e.g. metabolic disorders. The invention also provides methods of treating such disorders, and compounds and compositions etc. for their treatment.
    Type: Grant
    Filed: July 14, 2009
    Date of Patent: April 22, 2014
    Assignee: Novartis AG
    Inventors: Cornelia Jutta Forster, Young-Shin Kwak, Katsumasa Nakajima, Bing Wang
  • ORGANIC COMPOUNDS
    Publication number: 20100022513
    Abstract: The invention relates to compounds of formula (I): where A is an optionally substituted heteroaryl, useful for treating disorders mediated by acyl coA-diacylglycerol acyl transferase 1 (DGAT1), e.g. metabolic disorders. The invention also provides methods of treating such disorders, and compounds and compositions etc. for their treatment.
    Type: Application
    Filed: July 14, 2009
    Publication date: January 28, 2010
    Inventors: Cornelia Jutta Forster, Young-Shin Kwak, Katsumasa Nakajima, Bing Wang
  • 3-Cyano-3-(3,4-disubstituted) phenylcyclohexyl-1-carboxylates
    Patent number: 6300372
    Abstract: Novel 3-cyano-3-(3,4-disubstituted)phenylcyclohexyl-1-carboxylates or derivatives thereof and their corresponding cyclohexenyl analogs are described herein. These compounds inhibit the production of Tumor Necrosis Factor and are useful in the treatment of disease states mediated or exacerbated by TNF production. These compounds are also useful mediating or inhibiting the enzymatic or catalytic activity of phosphodiesterase IV and are therefore useful in treating diseases in need of mediation or inhibition thereof.
    Type: Grant
    Filed: January 30, 1996
    Date of Patent: October 9, 2001
    Assignee: SmithKline Beecham Corporation
    Inventors: Siegfried B. Christensen, IV, Cornelia Jutta Forster
  • Compounds useful for treating allergic or inflammatory diseases
    Patent number: 5811455
    Type: Grant
    Filed: May 24, 1995
    Date of Patent: September 22, 1998
    Assignee: SmithKline Beecham Corporation
    Inventors: Siegfried Benjamin Christensen, IV, Paul Elliot Bender, Cornelia Jutta Forster
  • Phenethylamine compounds
    Patent number: 5710180
    Abstract: Substituted phenethylamines of formula (I) useful for treating phosphodiesterase IV related ##STR1## disease states are disclosed herein.
    Type: Grant
    Filed: February 16, 1996
    Date of Patent: January 20, 1998
    Assignee: SmithKline Beecham Corporation
    Inventors: Siegfried Christensen, IV, Cornelia Jutta Forster